Shorepoint Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$356K Buy
+4,449
New +$380K 0.07% 89
2025
Q1
$431K Sell
4,599
-80
-2% -$7.16K 0.1% 86
2024
Q4
$425K Sell
4,679
-150
-3% -$14.3K 0.1% 87
2024
Q3
$501K Sell
4,829
-120
-2% -$12.2K 0.11% 84
2024
Q2
$480K Sell
4,949
-597
-11% -$55.1K 0.11% 86
2024
Q1
$499K Sell
5,546
-2,420
-30% -$205K 0.12% 82
2023
Q4
$635K Sell
7,966
-5,250
-40% -$395K 0.17% 79
2023
Q3
$940K Sell
13,216
-2,000
-13% -$150K 0.28% 79
2023
Q2
$1.17M Sell
15,216
-2,641
-15% -$204K 0.33% 77
2023
Q1
$1.34M Sell
17,857
-254
-1% -$18.9K 0.38% 72
2022
Q4
$1.43M Buy
+18,111
New +$1.36M 0.4% 75

Other funds holding CL

Shorepoint Capital Partners's CL Position: Q3 2025 in Review

Shorepoint Capital Partners opened a new position in Colgate-Palmolive (CL) in Q3 2025: 4,449 shares worth $356K. The stake represents 0.07% of the portfolio and ranks #89 among its holdings. This is a return to the name: Shorepoint Capital Partners previously reported a position in CL as recently as Q1 2025.

Shorepoint Capital Partners first reported a position in CL in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.43M in Q4 2022. 1,842 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Shorepoint Capital Partners held 4,449 shares of Colgate-Palmolive worth $356K as of Q3 2025.
  • Colgate-Palmolive was a new Shorepoint Capital Partners position in Q3 2025.
  • Colgate-Palmolive made up 0.07% of Shorepoint Capital Partners's portfolio in Q3 2025, its #89 holding.
  • Shorepoint Capital Partners first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 11 quarters since.
  • Shorepoint Capital Partners's Colgate-Palmolive position peaked at $1.43M in Q4 2022.
  • 1,842 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Shorepoint Capital Partners's 13F filing for Q3 2025, filed 3 Oct 2025.